Printer Friendly

Sanofi-Aventis SA.

SANOFI-AVENTIS SA., the biggest supplier of influenza shots to the U.S., signed an exclusive agreement with U.K. vaccine maker Acambis Plc to develop and market a product to fight the deadly West Nile virus. Acambis will receive $10 million now, and as much as $70 million more linked to the product's development and introduction. Sanofi said there is no preventive shot or treatment available for West Nile disease, a potentially fatal virus that has become endemic in the U.S. since it was first detected there in 1999. The experimental vaccine, which is in the second of three sets of tests for approval, helped more than 98% of the volunteers in studies develop antibodies against the virus.
COPYRIGHT 2007 MedContent Media, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:CORPORATE
Publication:MondayMorning
Date:Nov 19, 2007
Words:119
Previous Article:Nektar Therapeutics Inc.
Next Article:Abbott Laboratories Inc. (Abbott Park IL) won approval of a lower dose of the AIDS drug Kaletra in tablet form to treat children, the first step...

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters